Aiken C, Konner J, Landau NR, Lenburg ME, Trono D (1994) Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76(5), 853-864

Alfsen A, Iniguez P, Bouguyon E, Bomsel M (2001) Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol 166, 6257-6265

Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272(5270), 1955-1958

An SF, Groves M, Gray F, Scaravilli F (1999) Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 58(11), 1156-1162

Arthur LO, Bess JW Jr, Sowder RC 2nd, Benveniste RE, Mann DL, Chermann JC, Henderson LE (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Sciences 258(5090), 1935-1938

Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM (1995) Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Sciences 267, 1820-1825

Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey-Corb M, Ruprecht RM (1996) Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 272, 1486-1489

Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM(2000) Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 6, 200-206

Back NK (1993) HIV-1 neutralization: antibody specificity and possible viral escape mechanisms. Dissertation, Universität Amsterdam

Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996) Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10, 573-585

Baltimore D (1970) Viral-RNA dependent DNA polymerase: RNA dependent DNA polymerase in virions of RNA tumour viruses. Nature 226, 1209-1211

Banks WA, Kastin AJ, Akerstrom V (1997) HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sciences 61(9), 119-125

Barre-Sinoussi F, Cherman JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for AIDS. Science 220, 868

Bashirova AA, Geijtenbeek TBH, van Duijnhoven GCF, van Vliet SJ, Eilering JB, Martin MP, Wu L, Martin TD, Viebig N, Knolle PA, KewalRamani VN (2001 ) A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193, 671-678

Becquart P, Hocini H, Levy M, Sepou A, Kazatchkine MD, Belec L (2000 ). Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Inf Dis 181, 532-539

Bélec L, Ghys PD, Hocini H, Nkengasong JN, Tranchot-Diallo J, Diallo MO, Ettiègne-Traore V, Maurice C, Becquart P, Matta M, Si.Mohamed, Chomont N, Coulibaly IM, Wiktor SZ, Kazatchkine MD (2001) Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative african women. J Inf Dis 184, 1412-1422

Berkowitz RD, Goff SP (1994) Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology 202(1), 233-246

Bess JW Jr, Powell PJ, Issaq HJ, Schumack LJ, Grimes MK, Henderson LE, Arthur LO (1992) Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses. J Virol 66(2), 840-847

Bhat SR, Mettus V, Reddy EP, Ugen KE, Srikanthan V, Williams WV, Weiner DR (1993) The galactosyl ceramide/ sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Hum Retroviruses 9, 175-181

Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382(6594) , 829-833

Bomsel M (1997) Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 3(1), 42-47

Bomsel M, Heyman M, Hocini H, Lagaye S, Belec L, Dupont C, Desgranges C (1998 ) Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 9, 277-287

Bowen JM, Chamley L, Mitchell MD, Keelan JA (2002) Cytokines of the placenta and extra-placental membranes: biosynthesis secretion and roles in establishment of pregnancy in woman. Placenta 23, 239-256

Bowerman B, Brown PO, Bishop JM, Varmus HE (1989) A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 3(4), 469-478

Broliden K, Hinkula J, Devito C, Kiama P, Kimani J, Trabbatoni D, Bwayo JJ, Clerici M, Plummer F, Kaul R (2001) Fuctional HIV-1 specific IgA antibodies in HIV-1 exposed persistently IgG seronegative female sex workers. Immunol letters 79, 29-36

Brown DA, London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Del Biol 14, 103-114

Brown PO, Bowerman B, Varmus HE, Bishop JM (1989) Retroviral integration: structure of the initial covalent product and its precursors, and a role for the viral IN protein. Proc Natl Acad Sci USA 86(8), 2525-2529

Bry K, Hallman M (1992) Transforming growth factor-beta opposes the stimulatory effects of interleukin-1 and tumor nekrosis factor on amnion cell prostaglandin E2 production: implication for preterm labor. Am J Obstet Gynecol 167, 222-226

Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, Katinger K (1994) Generation of human monoclonal antibodies against HIV-1 proteins, electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses 10, 359-369

Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci USA 89(14), 6580-6584

Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M (1993) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 90(13), 6125-6129

Byrn RA, Zhang D, Eyre R, McGowan K, Kiessling AA (1997) HIV-1 in semen: an isolated virus reservoir. Lancet 350, 1141

Byrn RA, Kiessling AA (1998) Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir. J Reprod Immunol 41(1-2), 161-176

Carreno M-P, Krieff C, Irinopoulou T, Kazatchkine MD, Bélec L (2002) Enhanced transcytosis of R5-tropic human immunodeficiency virus across tight monolayer of polarized human endometrial cells under pro-inflammatory conditions. Cytokine 20(6), 289-294

CDC Centers for Disease Control (1992). 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 41, RR-17

Chen R, Quinones-Mateu ME, Mansky ML (2004) Drug resistance, virus fitness and HIV-1 mutagenesis. Curr Pharm Dess 10(32), 4065-4070

Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85(7), 1135-1148

Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Markolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387(6629), 183-188

Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM(1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 324 (14), 954-960

Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey MA, Santos-Ferreira O (1986) Isolation of a new human retrovirus from West African patients with AIDS. Science 233, 343

Coffin JM (1990) Retroviridae and their replication. Fundamental Virology, ed.: Fields BN, Knipe DM et al. Raven Press, Ltd., New York

Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T Lymphocytes. Nature 391(6665), 397-401

Compans RW, Dimmock NJ, Meier-Ewert H (1969) Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus. J Virol 4, 528-534

Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, McDonald S, Pulford KAF, Stein H, Mason DJ (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32, 219-229

Crawford S, Goff SP (1985) A deletion mutation in the 5`part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol 53(3), 899-907

Curtis BM, Scharnowske S, Watson AJ (1992) Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 89, 8356-8360

Dalgleish AG, Beverly PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312(5996), 763-767

Deng HK, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666

Devito C, Broliden K, Kaul R, Svensson L, Johansen K, Kiama P, Kimani J, Lopalco L, Piconi S, Bwayo JJ, Plummer F, Clerici M, Hinkula J (2000) Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 165, 5170-5176

Doms RW, Peiper SC (1997) Unwelcomed guests with master keys: how HIV uses Chemokines receptors for cellular entry. Virology 235(2), 179-190

Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β -chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 85, 1149

Dorfman T, mammano F, Haseltine WA, Gottlinger HG (1994) Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 68(3), 1689-1696

Doyle C, Strominger JL (1987) Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330(6145), 256-259

Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673

Earl PL, Doms RW, Moss B (1990) Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA 87(2), 648-652

Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TN, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA (1996) CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87(4), 745-756

Eshleman SH, Hoover DR, Shu Chen, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha Taha (2005) Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Inf Dis 192, 30-36

Farnet CM, Haseltine WA (1991) Determination of viral proteins in the human immunodeficiency virus type 1 preintegration complex. J Virol 64(4), 1910-1915

Fauci AS, Poli G (1993) Cytokine modulation of HIV expression. Semin Immunol 5(3), 165-173

Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877

Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17, 1871-1879

Flys T, Nissley DV, Claasen CW, Jones D, Chanjuan Shi, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH (2005) Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N Nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET012. J Inf Dis 192, 24-29

Franke EK, Yuan HE, Luban J (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372(6504), 359-362

Gallay P, Swingler S, Aiken C, Trono D (1995) HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80(3), 379-388

Gallo RC, Sarin PS, Gelmann EP, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, Leibowitch J, Popovic M (1983) Isolation of human T cell leukemia in acquired immune deficiency syndrome (AIDS). Science 220, 865

Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B et al. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503

Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF (1999) Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341(6), 394-402

Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y (2000) DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell100, 587-597

Gelderblom HR (1991) Assembly and morphology of HIV: potential effect of structure on viral function [editorial]. AIDS 5(6), 617-637

Gelderblom HR, Hausmann EH, Özel M, Pauli G, Koch MA (1987) Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156(1), 171-176

Gelderblom HR, Reupke H, Winkel T, Kunze R, Pauli G (1987 II) MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Z Naturforsch [C] 42(11-12), 1328-1334

Gendelman HE, Orenstein JM, Baca LM, Weiser B, Burger H, Kalter DC, Meltzer MS (1989) The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3(8), 475-495

Gortmaker SL, Hugher M, Cervia J, Brady M, Johnson GM, Seage GR 3rd, Song LY, Dankner WM, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team (2001) Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 345(21), 1522-1528

Grosch-Wörner I, Koch S, Vocks M, Schafer A, Mielke M, Wahn U, Zorr B, Maas U (1989) HIV-Infektion bei Kindern seropositiver Mütter (HIV infection in children of seropositive mothers). Arch Gyn Obstet 245(1-4), 185-188

Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354, 795-802

Hamed KA, Winters MA, Holodniy M, Katzenstein DA, Merigan TC (1993) Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy. J Infect Dis 167, 798-802

Hansen GH, Niels-Christiansen LL, Immerdal L, Hunziker W, Kenny AC, Danielsen EM (1999) Transcytosis of immunglobulin A in the mouse enterocyte occurs through glycolipid raft- and rab17-containing compartments. Gastroenterology 116, 610-622

Hansen WR, Keelan JA, Skinner SJ, Mitchell MD (1999) Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review. Prostaglandins Other Lipid Mediat 57, 243-257

Hardt O (2000) Nachweis der PND-spezifischen Immunantwort gegen HIV-1 gp120: Herstellung von Oligopeptiden, die sich aus der PND-Region ableiten, und Etablierung von ELISA-Testen. Dissertation, Medizinische Fakultät Charité der Humboldt-Universität Berlin

Harris M (1999) HIV: a new role for Nef in the spread of HIV. Curr Biol. 9(12), R459-461

Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelmann HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr Protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91(15), 7311-7315

Henderson LE, Bowers MA, Sowder RC 2nd, Serabyn SA, Johnson DG, Bess JW Jr, Arthur LO, Bryant DK, Fenselau C (1992) Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J Virol 66(4), 1856-1865

Hertelendy F, Romero R, Molnar M, Todd H, Baldassare JJ (1993) Cytokine-initiated signal transduction in human myometrial cells. Am J Reprod Immunol 30, 49-57

Hocini H, Bélec L, Iscaki S, Garin B, Pillot J, Becquart P, Bomsel M (1997) High-level ability of secretory IgA to block HIV type 1 transcytosis: Contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res Human Retroviruses 13(14), 1179-1185

Hocini H, Bomsel M (1999) Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J Infect Dis 179, 448-453

Hocini H, Becquart P, Bouhlal H, Chomont N, Ancuta P, Kazatchkine MD, Bélec L (2001) Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J Virol 75(11), 5370-5374

Hofmann-Lehmann R, Vlasak J, Rasmussen RA, Jiang S, Li PL, Baba LW, Montefiori DC, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Katinger H, Stiegler G, Cavacini LA, Posner MR, Ruprecht RM (2002) Postnatal pre- and post-exposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. J Med Primatology 31, 109-119

Hoxie JA (1991) Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. AIDS Res Hum Retroviruses 7, 495-500

Joag SV, Adany I, Li Z, Foresman L, Pinson DM, Wang C, Stephens EB, Raghavan R, Narayan O (1997) Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS. J Virol 71(5), 4016-4023

Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD et al (1989) Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 86(17), 6768-6772

Johnson JA, Li J, Morris L, Martinson N, Gray G, McIntyre J, Heneine W (2005) Emergence of drug-resistent HIV-1 after intrapartum administration of single-dose Nevirapine is substantially underestimated. J Inf Dis 192, 16-23

Kaerber G (1931) Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 162, 480

Kage A, Shoolian E, Rokos K, Özel M, Nuck R, Reutter W, Köttgen E, Pauli G (1998) Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles. J Virol 72(5), 4231-4236

Kallman J, Kihlstrom E (1997) Penetration of group B streptococci through polarized Madin Darby canine kidney cell. Pediatr Res 42, 799-804

Kiessling AA, Lamparelli N, Yin HZ, Seibel MM, Eyre RC (1995) Semen leucocytes: friends or foes? Fertil Steril 64, 196-198

Kiessling AA, Fitzgerald LM, Zhang D, Chhay H, Brettler D, Eyre RC, Steinberg J, McGowan K, Byrn RA (1998) Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retroviruses 14 (1), 33-41

Kinoshita T (1991) Biology of complement: the overture. Immunol Today 12(9), 291-295

Kirchner JT (1999) Maternal HIV levels correlate with perinatal transmission.Am Fam Physician 60(9), 2684-2687

Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312(5996), 767-768

Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM (1990) The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol 64(2), 621-629

Krieger JN, Coombs RW, Collier AC, Ross SO, Chaloupka K, Cummings DK, Murphy VL, Corey L (1991) Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J InfectDis 163(2), 386-388

Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685

Lagaye S, Derrien M, Menu E, Coito C, Tresoldi E, Mauclère P, Scarlatti G, Chahout G, Barré-Sinoussi F, Bomsel M, The European Network For The Study Of In Utero Transmission Of HIV-1 (2001) Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasiespecies across a trophoblastic barrier by both transcytosis and infection. J Virol75(10), 4780-4791

Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, Garcia P, Fowler MG, Mefenson L , Tuomala R (1996) Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 334(25), 1618-1623

Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ (1987) Delineation of a region of the human immunodeficiency virus type 1 gp 120 glycoprotein critical for interaction with the CD4 receptor. Cell 50(6), 975-985

Lee CN, Robinson J, Mazzara G, Cheng YL, Essex M, Lee TH (1995) Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein gp120 epitope. AIDS Res Hum Retroviruses 11, 777-781

Leonard CK, Spellman MW, riddle L, Harris RJ, Thomas JN, Gregory TJ (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265, 10373-10382

Li A, Baba TW, Sodroski J, Zolla-Pazner4 S, Gorny MK, Robinson J, Posner MR, Katinger H, Barbas III CF, Burton DR, Chou TC, Ruprecht RM (1997) Synergistic neutralization of a chimeric SIV/ HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Human Retroviruses13, 647-656

Li A, Katinger H, Posner MR, Cavacini L, Zolla-Pazner S, Gorny MK, Sodroski J, Chou TC, Baba TW, Ruprecht RM (1998) Synergistic neutralization of simian-human immunideficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and hightiter anti-human immunodeficiency virus type 1 immunoglobulins. J Virol 72, 3235-3240

Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Cataldo PT, Piazza M (1996) Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10(14), F51-56

Lu Y, Brosio P, Lafaile M, Li J, Collman RG, Sodroski J, Miller CJ (1996) Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol 70(5), 3045-3050

Lundin-Schiller S, Mitchell MD (1991) Prostaglandin production by human chorion leave cells on response to inflammatory mediators. Placenta 12, 353-363

Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47(3), 333-348

Mascola JR, Louder MK, VanCott TC, Sapan CV, Lambert JS, Muenz LR, Bunow B, Birx DL, Robb ML (1997) Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J Virol71, 7198-7206

Mascola JR, Lewis MG, Stiegler G, Harris D, VanCott TC, Hayes D, Louder MK, Brown CR, Sapan CV, Frankel SS, Lu Y, Robb ML, Katinger H, Birx DL (1999) Protection of Macaques against pathogenic simian/ human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 73, 4009-4018

Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG (2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/ SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6, 207-210

Mayaux MJ, Dussaix E, Isopet J, Rekacewicz C, Mendelbrot L, Ciraru-Vigneron N, Allemon MC, Chambrin V, Katlama C, Delfraissy JF, Puel J (1997) Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 175(1), 172-175

McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek LC, Reyes GR, Weissman IL (1988) Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53(1), 55-67

McDougal JS, Maddon PJ, Dalgleish AG, Clapham PR, Littman DR, Godfrey M, Maddon DE, Chess L, Weiss RA, Axel R (1986) The T4 glycoprotein is a cell-surface receptor for the AIDS virus. Cold Spring Harb Symp Quant Biol., 51 Pt 2, 703-711

Meier C, Oelschlaeger TA, Merkert H, Korhonen TK, Hacker J (1996) Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells. Infect Immun 64, 2391-2399

Mermin JH, Holodniy M, Katzenstein DA, Merigan TC (1991) Detection of human immunodeficency virus DNA and RNA in semen by polymerase chain reaction. J Infect Dis 164, 769-776

Mitchell MD, Edwin S, Romero RJ (1990) Prostaglandin biosynthesis by human decidual cells: effects of inflammatory mediators. Prostaglandins Leukotriens EFA 41, 35-38

Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H (1987) Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable domains. J Virol 61, 570-578

Moses AV, Nelson JA (1994) HIV infection of human brain capillary endothelial cells-implications for AIDS dementia. Adv Neuroimmunol 4, 239-247

Mullis KB, Falcoona F, Scharf S, Saiki R, Horn G, Ehrlich P (1986) Specific enzymatic amplification in vitro: the polymerase chain reaction. Cold Spring Harbor Symp Quant Biol 51, 263-273

Murphy PM (1996) Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7(1), 47-64

Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Ruker F, Katinger H (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67, 6642-6647

Niedrig M, Harthus HP, Broker M, Meleon R, Gelderblom H, Pauli G (1993) Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1. Hybridoma 12(4), 431-439

Nizet V, Kim KS, Stins M, Jonas m, Chi EY, Nguyen, Rubens CE (1997) Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 65, 5074-5081

Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382(6594), 833-835

Olsen G, Shields J (1984) Seminal lymphocytes, plasma and AIDS. Nature 309, 116-117

Orenstein JM, Meltzer MS, Phipps T, Gendelman HE (1988) Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor 1-treated human monocytes: an ultrstructural study. J Virol 62(8), 2578-2586

Panigrahi P, Bamford P, Horvath K, Morris JG, Gewolb IH (1996) Escherichia coli transcytosis in a Caco-2 cell model: implications in neonatal necrotizing enterocolitis. Pediatr Res 40, 415-421

Parker CE, Deterding LJ, Hager-Braun C, Binley JM, Schülke N, Katinger H, Moore JP, Tomer KB (2001) Fine definition of the epitop on the gp41 Glycoprotein of human immunideficiency virus type 1 for neutralizing monoclonal Antibody 2F5. J Virol 75(22), 10906-10911

Pedroza Martins L, Chenciner N, Wain-Hobson S (1992) Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp120 envelope sequence. Virology 191, 837-845

Pitt J, Henrard D, FitzGerald G, Mofenson L, Lew J, Hillyer G, Mendez H, Cooper E, Hanson C, Rich KC (2000) Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection and disease progression. For the Women and Infants Transmission Study. J Infect Dis 182(4), 1243-1246

Pöhlmann S, Soilleux EJ, Baribaud F, Leslie G, Morris LS, Trowsdale J, Lee B, Coleman N, Doms RW (2001) DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci USA 98, 2670-2675

Pollard SR, Rosa MD, Rosa JJ and Wiley DC (1992) Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region.EMBO J 11(2), 585-591.

Pollard JK, Mitchell MD (1996) Intrauterine infection and the effects of inflammatory mediators on prostaglandin production by myometrial cells from pregnant woman. Am J Obstet Gynecol 174, 682-686

Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barret N, Jungbauer A et al. (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Research in Human Retroviruses 10, 1651-1658

Purtscher M, Trkola A, Grassauer A, Schulz PM, Klima A, Döpper S, Gruber G, Buchacher A, Muster T, Katinger H (1996) Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS 13, 137-162

Quayle AJ, Xu C, Mayer KH, Anderson DJ (1997) T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 176(4), 960-968

Reed LJ & Muench HA (1938) A simple method of estimating fifty per cent endpoints. Am. Journal Hyg. 27, 493

Reil H, Kollmus H, Weidle UH, Hauser H (1993) A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells. J Virol 67(9), 5579-5584

Resnick L, Berger JR, Shapshak P, Tourtellotte WW (1988) Early penetration of the blood-brain-barrier by HIV. Neurology 38(1), 9-14

Rietveld A, Simons K (1998) The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochem. Biophys. Acta 1376, 467-479

Rokos K, Wang H, Seeger J, Schäfer A, Pauli G (1998) Transport of viruses through fetal membranes: an in vitro model of perinatal transmission. J Med Virol 54, 313-319

Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD (1989) Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 37, 13-22

Rosen CA, Sodroski JG, Haseltine WA (1985) Location of cis-acting regulatory sequences in the human T-cell leukemia virus type 1 long terminal repeat. Proc Natl Acad Sci USA 82, 6502-6506

Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491

Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A Laboratory Manual. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY

Sanders RW, Venturi M, Schiffner L, Kalyanaraman R, Katinger H, Lloyd KO, Kwong PD, Moore JP (2002) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunideficiency virus type 1glycoprotein gp120. J Virol 76(14), 7293-7305

Sanger F, Nicklen S, Coulsen AR (1992) DNA sequencing with chain-terminating inhibitors.1977. Biotechnologie 24, 104-108

Scalan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, Wilson IA, Katinger H, Dwek RA, Rudd PM, Burton DR (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α 1 2 mannose residues on the outer face of gp120. J Virol 76(14), 7306-7321

Schmidt W (1992) The amniotic fluid compartment: the fetal habitat. Adv Anat Embryol Cell Biol 127, 1-100

Seeger J (2003) Transport von Viren durch Epithelzellen: Modellsystem für intrauterine Infektion und zur Virusübertragung über Schleimhäute. Dissertation, Humboldt Universität, Berlin

Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR (1994) Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343(8913), 1593-1597

Simons K, van Meer G (1988) Lipid sorting in epithelial cells. Biochemistry 27, 6197-6202

Sodora DL, Lee F, Dailey PJ, Marx PA (1998) A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res Human Retroviruses 14, 171-181

Soilleux EJ, Barten R, Trowsdale J (2000) DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 165, 2937-2942

Soilleux EJ, Coleman N (2003) Transplacental transmission of HIV: a potential role for HIV binding lectins. IJBCB 35, 283-287

South TL, Blake PR, Sowder RC 3rd, Arthur LO, Henderson LE, Summers MF (1990) The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry 29(34), 7786-7789

Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, Wong-Staal F (1986) Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45, 637-648

Stiegler G, Armbruster C, Vcelar B, Stoiber H, Kunert R, Michael NL; Jagodzinski, Ammann C, Jäger W, Jacobson J, Vetter N, Katinger H (2002) Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase 1 evaluation. AIDS 16, 2019-2025

Sutthent R, Foongladda S, Chearskul S, Wanaprapa N, Likanonskul S, Kositanont U, Riengrojpitak S, Sahapong S, Wasi C et al. (1997) Maternal and viral factors in vertical transmission of HIV-1 subtype E. Southeast Asian J Trop Med Public Health 28(4), 689-698

Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA (1989) Functional role of human immunodeficiency virus type 1vpu. Proc Natl Acad Sci USA 86(13), 5163-5167

Tomlinson MJ, White A, Barratt CL, Bolton AE, Cooke ID (1992) The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocytes? Hum Reprod 7, 517-522

Travis BM, Dykers TI, Hewgill D, Ledbetter J, Tsu TT, Hu SL, Lewis JB (1992) Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in formation of syncytia in CD4+ cells. Virology 186, 313-317

Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunideficiency virus type 1. J Virol 70, 1100-1108

Varmus H, Swanstrom R (1991) Replication of retroviruses. Weiss R, Teich N, Varmus H et al. eds. RNA tumor viruses: molecular biology of tumor viruses. Cold Spring Harbour, New York: Cold Spring Harbour Laboratories, 369-512

Verkade P, Harder T, Lafont F, Simons K (2000) Induction of caveolae in the apical plasma membrane of Mardin-Darby canine kidney cells. J. Cell. Biol. 148, 727-739

von der Helm K (1996) Retroviral proteases: structure, function and inhibition from a non-anticipated viral enzyme to the target of a most promising HIV therapy. Biol Chem 377(12), 765-74

Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon M (1985) Nucleotide sequence of the AIDS virus, LAV. Cell 40(1), 9-17

Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MBA (1986 ) Cellular localization of human immunodeficiency virus infection within the brains od aquired immune deficiency patients. Proc Natl Acad Sci USA 83, 7089-7093

Willey RL, Rutledge RA, Dias S, Folks T, Theodore T, Buckler CE, Martin MA (1986) Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc Natl Acad Sci USA83, 5038-5042

Willey RL, Maldarelli F, Martin MA, Strebel K (1992) Human Immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol66(1), 226-234

Wolbank S, Kunert R, Stiegler G, Katinger H (2003) Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. J Virol 77(7), 4095-4103

Xu W, Smith-Franklin BA, Li PL; Wood C, He J, Du Q, Bhat GJ, Kankasa C, Katinger H, Cavacini LA, Posner MR, Burton DR, Chou TC, Ruprecht RM (2001) Potent neutralization of primary human immunodificiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. J Hum Virol 4, 55-61

Yu X, Yuan X, Matsuda Z, Lee TH, Essex M (1992) The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol 66(8), 4966-4971

Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61(2), 213-222

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: